Showing results (231-240 of 249) with videos related to
Sort By:
Pageof 25
The American Journal of Tropical Medicine and Hygiene|January 1, 1993
Liver sonography in an area endemic for schistosomiasis haematobiumI A Eltoum, A M Saad, B M Ismail, et al.Cell Transplantation|November 25, 2010
NUP98-HOXA10hd-expanded hematopoietic stem cells efficiently reconstitute bone marrow of mismatched recipients and induce toleranceY Even, J L Bennett, S Sekulovic, et al.Journal of Veterinary Pharmacology and Therapeutics|June 1, 1988
Development of a novel in vitro equine anthelmintic assayS D Folz, R A Pax, T R Klei, et al.The British Journal of Surgery|July 1, 1994
Predictors of upper gastrointestinal bleeding in patients with schistosomal periportal fibrosisI A Eltoum, T E Taha, A M Saad, et al.Lancet (London, England)|August 20, 1988
Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villagesM A Homeida, A Fenwick, A A DeFalla, et al.Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endotheliumJ N Topper, J Cai, Y Qiu, et al.The American Journal of Tropical Medicine and Hygiene|February 1, 1996
The effectiveness of annual versus biennial mass chemotherapy in reducing morbidity due to schistosomiasis: a prospective study in Gezira-Managil, SudanM M Homeida, I A Eltoum, M M Ali, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1990
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasisM E Mandour, H el Turabi, M M Homeida, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studiesN V Dimitrov, C M Leece, E R Tompkins, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2026
Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trialJ L Bennett, S Bhattacharyya, A Zabeti, et al.Pageof 25